Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biohaven
3
×
biotech
3
×
life sciences
national
3
×
national blog main
national top stories
new york blog main
allergan
amgen
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
eli lilly
fda
indiana blog main
indiana top stories
migraine
new york top stories
raleigh-durham blog main
raleigh-durham top stories
rimegepant
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
acc
acquisition
activist investor
aducanumab
What
approved
class
drug
fda
migraine
new
adu
adults
allergan
approval
arguments
beats
bids
big
bio
biogen
commercialized
companies
competitors
complicated
decades
depression
dire
drugs
good
group
heart
help
make
medical
medicines
meeting
monday
need
neuro
news
nod
oral
people
pill
Language
unset
Current search:
biohaven
×
biotech
×
national
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More